申请人:Abbott Laboratories
公开号:US20040116518A1
公开(公告)日:2004-06-17
The present invention relates to novel cinnamide compounds that are useful for treating inflammatory and immune diseases and cerebral vasospasm, to pharmaceutical compositions containing these compounds, and to methods of inhibiting inflammation or suppressing immune response in a mammal.
本发明涉及新型肉桂酰胺化合物,用于治疗炎症和免疫性疾病以及脑血管痉挛,以及含有这些化合物的药物组合物,以及在哺乳动物中抑制炎症或抑制免疫反应的方法。